$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000163297017000022 Filed on March 01, 2017

Income Statement

Concept	2016 Q4	2016 Q3	2016
Revenue	$2.818M	$214.0K	$3.156M
YoY Change
Cost Of Revenue			$898.0K
YoY Change
Gross Profit			$2.258M
YoY Change
Gross Profit Margin			71.55%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$40.00K	$1.252M
YoY Change
% of Gross Profit			55.45%
Operating Expenses			$437.0K
YoY Change
Operating Profit	-$2.161M	-$2.036M	-$4.960M
YoY Change
Interest Expense		$56.00K	$514.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$458.0K	$56.00K
YoY Change
Pretax Income			-$5.474M
YoY Change
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.619M	-$2.092M	-$5.474M
YoY Change
Net Earnings / Revenue	-92.94%	-977.57%	-173.45%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	7.784M shares	2.844M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.237M	$2.575M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$19.67M	$6.866M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$142.8M	$65.66M
YoY Change	70572.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$50.50M	$22.70M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$7.351M	-$3.453M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$92.26M	$42.95M
YoY Change
Total Liabilities & Shareholders Equity	$142.8M	$65.66M
YoY Change	70572.28%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016
OPERATING ACTIVITIES
Net Income	-$2.619M	-$2.092M	-$5.474M
YoY Change
Depreciation, Depletion And Amortization		$40.00K	$1.252M
YoY Change
Cash From Operating Activities			-$3.621M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			-$133.3M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$111.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$139.0M
YoY Change
NET CHANGE
Cash From Operating Activities			-$3.621M
Cash From Investing Activities			-$133.3M
Cash From Financing Activities			$139.0M
Net Change In Cash			$2.035M
YoY Change
FREE CASH FLOW
Cash From Operating Activities			-$3.621M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-01-23
CY2016Q2	dei	Entity Public Float EntityPublicFloat	15363000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Griffin-American Healthcare REIT IV, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Trading Symbol TradingSymbol	gahr4
CY2015Q4	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	0	USD
CY2016Q4	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	5404000	USD
CY2015Q4	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	0	USD
CY2016Q4	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	3973000	USD
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice	138820000	USD
CY2016Q1	gahr	Aggregate Maximum Amount Of Common Stock Issuable Under Public Offering AggregateMaximumAmountOfCommonStockIssuableUnderPublicOffering	3150000000	USD
CY2016Q2	gahr	Aggregate Reallocated Maximum Amountof Common Stock Issuable Under Primary Public Offering AggregateReallocatedMaximumAmountofCommonStockIssuableUnderPrimaryPublicOffering	3150000000	USD
CY2016	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	2000	USD
CY2016	gahr	Assetmanagementfeeswaivedbyadvisor Assetmanagementfeeswaivedbyadvisor	80000	USD
CY2016	gahr	Borrowingsandassumptionsonmortgageloanspayablenet Borrowingsandassumptionsonmortgageloanspayablenet	4129000	USD
CY2016	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	103000	USD
CY2016	gahr	Dealer Manager Fees DealerManagerFees	1106000	USD
CY2016	gahr	Distribution Classified As Capital Gain DistributionClassifiedAsCapitalGain	0	USD
CY2016	gahr	Distributions Classified As Ordinary Income DistributionsClassifiedAsOrdinaryIncome	0	USD
CY2016	gahr	Distributions Classified As Return Of Capital DistributionsClassifiedAsReturnOfCapital	1345000	USD
CY2016	gahr	Distributions Reportable DistributionsReportable	1345000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	172000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	265000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	51000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	73000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	237000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	265000	USD
CY2016Q4	gahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	1063000	USD
CY2016Q3	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension
CY2016Q3	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2016Q3	gahr	Line Of Credit Facility Potential Increase Amount To Borrowing Capacity LineOfCreditFacilityPotentialIncreaseAmountToBorrowingCapacity	100000000	USD
CY2016Q3	gahr	Line Of Credit Facility Potential Maximum Borrowing Capacity LineOfCreditFacilityPotentialMaximumBorrowingCapacity	200000000	USD
CY2016	gahr	Lines Of Credit Related To Acquisition Of Properties LinesOfCreditRelatedToAcquisitionOfProperties	90700000	USD
CY2016Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	32957000	USD
CY2016Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.150
CY2016Q1	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.150
CY2016Q1	gahr	Maximum Percentage Of Common Stock Repurchased During Period MaximumPercentageOfCommonStockRepurchasedDuringPeriod	0.050
CY2016	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2016Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.050
CY2016Q1	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.100
CY2016Q4	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2016Q4	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.1
CY2016	gahr	Mortgage Loans Payable Related To Acquisition Of Properties MortgageLoansPayableRelatedToAcquisitionOfProperties	3968000	USD
	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	USD
CY2016	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	2000	USD
	gahr	Number Of Buildings Acquired From Unaffiliated Parties NumberOfBuildingsAcquiredFromUnaffiliatedParties	12	Building
CY2016Q4	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	3
	gahr	Numberof Acquisitions Completedfrom Unaffiliated Parties NumberofAcquisitionsCompletedfromUnaffiliatedParties	9	Acquisition
CY2016Q1	gahr	Officer Purchase Share Price OfficerPurchaseSharePrice	9.60
	gahr	Other Amortization OtherAmortization	0	USD
CY2016	gahr	Other Amortization OtherAmortization	104000	USD
CY2016	gahr	Ownership Percentage Properties OwnershipPercentageProperties	1
CY2016	gahr	Ownership Percentage Properties OwnershipPercentageProperties	1.00
CY2016	gahr	Percentage Distributions Reportable PercentageDistributionsReportable	1
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
CY2016	gahr	Percentage Of Distributions Classified As Capital Gain PercentageOfDistributionsClassifiedAsCapitalGain	0.00
CY2016	gahr	Percentage Of Distributions Classified As Ordinary Income PercentageOfDistributionsClassifiedAsOrdinaryIncome	0.00
CY2016	gahr	Percentage Of Distributions Classified As Return Of Capital PercentageOfDistributionsClassifiedAsReturnOfCapital	1.00
CY2016Q4	gahr	Percentage Of Income Required To Be Distributed As Dividends PercentageOfIncomeRequiredToBeDistributedAsDividends	0.900
CY2015Q4	gahr	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	0	USD
CY2016Q4	gahr	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	257000	USD
CY2015Q4	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	0	USD
CY2016Q4	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	1015000	USD
CY2016	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	2000	USD
CY2016	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	2000	USD
CY2016	gahr	Selling Commissions Expenses SellingCommissionsExpenses	3045000	USD
	gahr	Selling Commissions Percentage SellingCommissionsPercentage	0.030
CY2016Q4	gahr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Expected To Vest Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpectedToVestNumber	12000	shares
CY2016Q4	gahr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Expected To Vest Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpectedToVestWeightedAverageGrantDateFairValue	10.00
CY2016Q1	gahr	Share Repurchase Plan Holding Period Condition One ShareRepurchasePlanHoldingPeriodConditionOne	P1Y
CY2016Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition One ShareRepurchasePlanPercentageofPriceperShareConditionOne	0.925
CY2016Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition Two ShareRepurchasePlanPercentageofPriceperShareConditionTwo	1.00
	gahr	Sharesissuedindiscount Sharesissuedindiscount	0	USD
CY2016	gahr	Sharesissuedindiscount Sharesissuedindiscount	59000	USD
CY2016	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	4052000	USD
CY2016Q4	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	3973000	USD
	gahr	Stockholderdailyservicingfeepercentage Stockholderdailyservicingfeepercentage	0.010
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	0	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5426000	USD
CY2015Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	0	USD
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1299000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99492000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	50000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	13618000	USD
CY2016	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	60000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	112000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	483000	USD
CY2016Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	623000	sqft
CY2016	us-gaap	Asset Management Fees1 AssetManagementFees1	151000	USD
CY2015Q4	us-gaap	Assets Assets	202000	USD
CY2015Q4	us-gaap	Assets Assets	202000	USD
CY2016Q4	us-gaap	Assets Assets	142758000	USD
CY2016Q4	us-gaap	Assets Assets	142758000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2016	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4745000	USD
CY2015Q4	us-gaap	Cash Cash	202000	USD
CY2016Q4	us-gaap	Cash Cash	2237000	USD
CY2015Q1	us-gaap	Cash Cash	0	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	202000	USD
CY2016	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	2035000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2016Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	229000	USD
	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	0	USD
CY2016	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	898000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	0	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	150000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	639000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	2348000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	4979000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	8116000	USD
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3908000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3908000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	14000	USD
CY2016Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0430
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2015Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	0	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	943000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	USD
CY2016Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	207000	USD
	us-gaap	Depreciation Depreciation	0	USD
CY2016	us-gaap	Depreciation Depreciation	822000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1252000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1252000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1877000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	532000	USD
CY2015Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2016Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	5531000	USD
CY2015Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	USD
CY2016Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5531000	USD
CY2015Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	0	USD
CY2016Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	200000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.20
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.75
CY2016	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P28Y7M6D
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9941000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2227000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1633000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1778000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1995000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2099000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	19673000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1221000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	USD
CY2016	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	284000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	770000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	127000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	31000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19673000	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2016	us-gaap	Interest Expense InterestExpense	514000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
CY2016	us-gaap	Interest Paid InterestPaid	203000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	0	USD
CY2016Q4	us-gaap	Liabilities Liabilities	50501000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	202000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	142758000	USD
	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9900
CY2016	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0100
CY2016	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	33900000	USD
CY2016Q3	us-gaap	Line Of Credit Facility Collateral LineOfCreditFacilityCollateral	750000000
CY2016Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	33899000	USD
CY2016Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000	USD
CY2016Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	66100000	USD
CY2016Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	4131000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2492000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	314000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	298000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	282000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	268000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	254000	USD
CY2015Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	33900000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	2000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2015Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0100
CY2016Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2015Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9900
CY2016Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	202000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138978000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133322000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3621000	USD
	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-150000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-613000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-2092000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-2619000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-5474000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	239000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
CY2016	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4129000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	648000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	212000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2000	USD
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2016Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	4	State
CY2015Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	0	USD
CY2016Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1063000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	0	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-150000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-613000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2036000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2161000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-4960000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2919000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	32000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	33000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	33000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	33000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	32000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2756000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	89423000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	11078000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	10190000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	10627000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	11174000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	11095000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	35259000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	0	USD
CY2016	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	3156000	USD
	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2015-02-06
CY2015Q4	us-gaap	Other Assets OtherAssets	0	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	0	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	1407000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	1407000	USD
CY2016Q1	us-gaap	Other Expenses OtherExpenses	0	USD
CY2016Q2	us-gaap	Other Expenses OtherExpenses	0	USD
CY2016Q3	us-gaap	Other Expenses OtherExpenses	56000	USD
CY2016Q4	us-gaap	Other Expenses OtherExpenses	458000	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	0	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	616000	USD
CY2016	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	898000	USD
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	5000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	0	USD
CY2016	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	23000	USD
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	0	USD
CY2016	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	200000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	549000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1146000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4191000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2016	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	133099000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	111024000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	90700000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2000	USD
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
	us-gaap	Profit Loss ProfitLoss	0	USD
	us-gaap	Profit Loss ProfitLoss	0	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-150000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-613000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-2092000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	-2619000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-5474000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-5474000	USD
CY2015Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	0	USD
CY2016Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	822000	USD
CY2016Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	822000	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	0	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	822000	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	3908000	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	106442000	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	12322000	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	23000	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	106419000	USD
CY2016Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	12322000	USD
CY2016Q4	us-gaap	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	142115000	USD
CY2015Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	0	USD
CY2016Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	118764000	USD
CY2016Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	118764000	USD
CY2015Q1	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	0	USD
	us-gaap	Real Estate Improvements RealEstateImprovements	0	USD
CY2016	us-gaap	Real Estate Improvements RealEstateImprovements	23000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	0	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	822000	USD
CY2015Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	0	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	118764000	USD
CY2015Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	0	USD
CY2015Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	0	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	117942000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	117942000	USD
	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	0	USD
CY2016	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	118741000	USD
	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2016	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2016Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	0	USD
CY2016Q2	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	26000	USD
CY2016Q3	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	312000	USD
CY2016Q4	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	2818000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	0	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	0	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2016	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9112000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	56800000	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	60000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7351000	USD
CY2016	us-gaap	Revenues Revenues	2258000	USD
CY2015Q4	us-gaap	Secured Debt SecuredDebt	0	USD
CY2016Q4	us-gaap	Secured Debt SecuredDebt	3965000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	80000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	15000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.00
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	12000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	10.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	3000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	10.00
CY2015Q4	us-gaap	Shares Issued SharesIssued	20833	shares
CY2016Q4	us-gaap	Shares Issued SharesIssued	11377439	shares
CY2016Q4	us-gaap	Shares Issued SharesIssued	11377439	shares
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	796000	USD
CY2016	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	83717	shares
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	USD
CY2016	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	796000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	112148000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	200000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	92255000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	202000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	92255000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0	USD
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	0	USD
CY2016	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	207000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20833	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20833	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	635808	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3357979	shares
CY2016Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8450304	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3131466	shares
CY2016	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization and Description of Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Griffin-American Healthcare REIT IV, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;">January 23, 2015</font><font style="font-family:inherit;font-size:10pt;"> and therefore we consider that our date of inception. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, hospitals, skilled nursing facilities, senior housing and other healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income. We intend to elect to be treated as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes beginning with our taxable year ended December 31, 2016.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2016, we commenced our initial public offering, or our offering, in which we were offering to the public a minimum of </font><font style="font-family:inherit;font-size:10pt;">$2,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock, or the minimum offering, and a maximum of </font><font style="font-family:inherit;font-size:10pt;">$3,000,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock in our primary offering at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share. Effective June 17, 2016, we reallocated certain of the unsold shares of Class T common stock being offered and began offering shares of Class I common stock, such that we are currently offering up to approximately </font><font style="font-family:inherit;font-size:10pt;">$2,800,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class T common stock and </font><font style="font-family:inherit;font-size:10pt;">$200,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class I common stock in our primary offering, and up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T and Class I common stock pursuant to our distribution reinvestment plan, as amended, or the DRIP, aggregating up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;">, or the maximum offering. The shares of our Class T common stock in our primary offering are being offered at a price of $10.00 per share. The shares of our Class I common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.30</font><font style="font-family:inherit;font-size:10pt;"> per share prior to March 1, 2017 and at </font><font style="font-family:inherit;font-size:10pt;">$9.21</font><font style="font-family:inherit;font-size:10pt;"> per share for all shares offered on or after March 1, 2017. </font><font style="font-family:inherit;font-size:10pt;">See Note 21, Subsequent Events</font><font style="font-family:inherit;font-size:10pt;"> — Amendment to Dealer Manager Agreement and Change to Class I Common Stock Offering Price, for a further discussion. The shares of our Class T and Class I common stock issued pursuant to the DRIP were sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share prior to January 1, 2017 and at </font><font style="font-family:inherit;font-size:10pt;">$9.40</font><font style="font-family:inherit;font-size:10pt;"> per share for all shares issued pursuant to the DRIP on or after January 1, 2017 until our board of directors determines an estimated net asset value, or NAV, per share for our Class T shares. After our board of directors determines an estimated NAV per share of our Class T shares, participants in the DRIP will receive Class T shares and Class I shares, as applicable, at the most recently published estimated NAV per share of our Class T shares. We reserve the right to reallocate the shares of common stock we are offering between the primary offering and the DRIP, and among classes of stock.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The conditions of our minimum offering were satisfied on April 12, 2016, and we admitted our initial public subscribers as stockholders, excluding shares purchased by residents of Ohio, Washington and Pennsylvania (who were subject to higher minimum offering amounts). Having raised the minimum offering, the offering proceeds were released by the escrow agent to us on April 13, 2016 and were made available for the acquisition of properties and other purposes as disclosed in our prospectus dated February 16, 2016, as supplemented, or our prospectus, as filed with the United States Securities and Exchange Commission, or the SEC (provided that subscriptions from residents of Ohio, Washington and Pennsylvania were to continue to be held in escrow until we had received and accepted subscriptions aggregating at least </font><font style="font-family:inherit;font-size:10pt;">$10,000,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;">, respectively). The conditions of our minimum offering in Ohio, Washington and Pennsylvania were satisfied on June 14, 2016, July 8, 2016 and February 27, 2017, respectively, and as of such dates we were able to admit Ohio, Washington and Pennsylvania subscribers as stockholders.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, we had received and accepted subscriptions in our offering for </font><font style="font-family:inherit;font-size:10pt;">11,257,889</font><font style="font-family:inherit;font-size:10pt;"> aggregate shares of our Class T and Class I common stock, or approximately </font><font style="font-family:inherit;font-size:10pt;">$112,079,000</font><font style="font-family:inherit;font-size:10pt;">, excluding subscriptions from residents in Pennsylvania (who we were not able to admit as stockholders until February 27, 2017 when we had received and accepted subscriptions aggregating at least </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;">) and shares of our common stock issued pursuant to the DRIP. </font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. We are externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or Griffin-American Healthcare REIT IV Advisor, or our advisor, pursuant to an advisory agreement, or the Advisory Agreement, between us and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a one-year term, subject to successive one-year renewals upon the mutual consent of the parties. The Advisory Agreement was renewed pursuant to the mutual consent of the parties on February 13, 2017 and expires on February 16, 2018. Our advisor uses its best efforts, subject to the oversight and review of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our advisor is </font><font style="font-family:inherit;font-size:10pt;">75.0%</font><font style="font-family:inherit;font-size:10pt;"> owned and managed by American Healthcare Investors, LLC, or American Healthcare Investors, and </font><font style="font-family:inherit;font-size:10pt;">25.0%</font><font style="font-family:inherit;font-size:10pt;"> owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital (formerly known as Griffin Capital Corporation), or collectively, our co-sponsors. Effective March 1, 2015, American Healthcare Investors is </font><font style="font-family:inherit;font-size:10pt;">47.1%</font><font style="font-family:inherit;font-size:10pt;"> owned by AHI Group Holdings, LLC, or AHI Group Holdings, </font><font style="font-family:inherit;font-size:10pt;">45.1%</font><font style="font-family:inherit;font-size:10pt;"> indirectly owned by Colony NorthStar, Inc. (NYSE: CLNS), or Colony NorthStar (formerly known as NorthStar Asset Management Group Inc. prior to its merger with Colony Capital, Inc. and NorthStar Realty Finance Corp. on January 10, 2017), and </font><font style="font-family:inherit;font-size:10pt;">7.8%</font><font style="font-family:inherit;font-size:10pt;"> owned by James F. Flaherty III, one of Colony NorthStar’s partners. We are not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or Griffin Capital Securities, or our dealer manager, Colony NorthStar or Mr. Flaherty; however, we are affiliated with Griffin-American Healthcare REIT IV Advisor, American Healthcare Investors and AHI Group Holdings.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently operate through two reportable business segments — medical office buildings and senior housing. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, we had completed </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> property acquisitions comprising </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> buildings, or approximately </font><font style="font-family:inherit;font-size:10pt;">623,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of gross leasable area, or GLA, for an aggregate contract purchase price of </font><font style="font-family:inherit;font-size:10pt;">$138,820,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001632970-17-000022-index-headers.html	Edgar Link	pending
0001632970-17-000022-index.html	Edgar Link	pending
0001632970-17-000022.txt	Edgar Link	pending
0001632970-17-000022-xbrl.zip	Edgar Link	pending
ex211-gahr4x10xk2016xq4.htm	Edgar Link	pending
ex311-gahr4x10xk2016xq4.htm	Edgar Link	pending
ex312-gahr4x10xk2016xq4.htm	Edgar Link	pending
ex321-gahr4x10xk2016xq4.htm	Edgar Link	pending
ex322-gahr4x10xk2016xq4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gahr-20161231.xml	Edgar Link	completed
gahr-20161231.xsd	Edgar Link	pending
gahr-20161231_cal.xml	Edgar Link	unprocessable
gahr-20161231_def.xml	Edgar Link	unprocessable
gahr-20161231_lab.xml	Edgar Link	unprocessable
gahr-20161231_pre.xml	Edgar Link	unprocessable
gahr4-10xk2016xq4.htm	Edgar Link	pending
gahr4orgchart020817a01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2016 Q4 Form 10-K Financial Statement

#000163297017000022 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2016 Q4 Form 10-K Financial Statement

#000163297017000022 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr